Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Aug 1, 2026 | Regence BCBS | Hematopoietic Cell Transplantation for Solid Tumors of ChildhoodPayerPolicy · REGENCE-TRA45.37 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Hematopoietic Cell Transplantation for Non-Hodgkin's LymphomasPayerPolicy · REGENCE-TRA45.23 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Hematopoietic Cell Transplantation for Multiple Myeloma and POEMS SyndromePayerPolicy · REGENCE-TRA45.22 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Hematopoietic Cell Transplantation for Miscellaneous Solid Tumors in AdultsPayerPolicy · REGENCE-TRA45.27 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Hematopoietic Cell Transplantation for Light-Chain (AL) Amyloidosis or Waldenström MacroglobulinemiaPayerPolicy · REGENCE-TRA45.40 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Hematopoietic Cell Transplantation for Hodgkin LymphomaPayerPolicy · REGENCE-TRA45.30 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Hematopoietic Cell Transplantation for Chronic Myelogenous LeukemiaPayerPolicy · REGENCE-TRA45.31 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia and Small Lymphocytic LymphomaPayerPolicy · REGENCE-TRA45.35 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Hematopoietic Cell Transplantation for Central Nervous System Embryonal Tumors and EpendymomaPayerPolicy · REGENCE-TRA45.33 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Hematopoietic Cell Transplantation for Autoimmune DiseasesPayerPolicy · REGENCE-TRA45.32 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Hematopoietic Cell Transplantation for Acute Myeloid LeukemiaPayerPolicy · REGENCE-TRA45.28 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Hematopoietic Cell Transplantation for Acute Lymphoblastic LeukemiaPayerPolicy · REGENCE-TRA45.36 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Heart-Lung TransplantPayerPolicy · REGENCE-TRA03 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Heart TransplantPayerPolicy · REGENCE-TRA02 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | H-wave StimulationPayerPolicy · REGENCE-DME83.02 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Genotyping for 9p21 Single Nucleotide Variants to Predict Risk of Cardiovascular Disease or AneurysmPayerPolicy · REGENCE-GT62 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Genetic Testing for the Evaluation of Products of Conception and Pregnancy LossPayerPolicy · REGENCE-GT79 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Genetic Testing for the Diagnosis of Inherited Peripheral NeurophathiesPayerPolicy · REGENCE-GT66 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Genetic Testing for Statin-Induced MyopathyPayerPolicy · REGENCE-GT50 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Genetic Testing for Rett SyndromePayerPolicy · REGENCE-GT68 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Genetic Testing for PTEN Hamartoma Tumor SyndromePayerPolicy · REGENCE-GT63 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Genetic Testing for Primary Mitochondrial DisordersPayerPolicy · REGENCE-GT54 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Genetic Testing for Neurofibromatosis Type 1 or 2PayerPolicy · REGENCE-GT84 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Genetic Testing for Myeloid Neoplasms and LeukemiaPayerPolicy · REGENCE-GT59 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Genetic Testing for Methionine Metabolism Enzymes, including MTHFRPayerPolicy · REGENCE-GT65 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Genetic Testing for Macular DegenerationPayerPolicy · REGENCE-GT75 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Genetic Testing for Lynch Syndrome and APC-associated and MUTYH-associated Polyposis SyndromesPayerPolicy · REGENCE-GT06 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Genetic Testing for Lactase InsufficiencyPayerPolicy · REGENCE-GT67 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Genetic Testing for Heritable Disorders of Connective TissuePayerPolicy · REGENCE-GT77 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Genetic Testing for Hereditary Breast, Ovarian, Pancreatic and Prostate Cancer and Li-Fraumeni SyndromePayerPolicy · REGENCE-GT02 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Genetic Testing for Familial HypercholesterolemiaPayerPolicy · REGENCE-GT11 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Genetic Testing for EpilepsyPayerPolicy · REGENCE-GT80 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Genetic Testing for Duchenne and Becker Muscular DystrophyPayerPolicy · REGENCE-GT69 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Genetic Testing for Diagnosis and Management of Behavioral Health ConditionsPayerPolicy · REGENCE-GT53 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Genetic Testing for Cutaneous Malignant MelanomaPayerPolicy · REGENCE-GT08 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Genetic Testing for CADASIL SyndromePayerPolicy · REGENCE-GT51 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Genetic Testing for Biallelic RPE65 Variant-Associated Retinal DystrophyPayerPolicy · REGENCE-GT21 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Genetic Testing for Alzheimer's DiseasePayerPolicy · REGENCE-GT01 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Genetic Testing for Alpha-1 Antitrypsin DeficiencyPayerPolicy · REGENCE-GT61 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Genetic and Molecular Diagnostic TestingPayerPolicy · REGENCE-GT20 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | General Medical Necessity Guidance for Durable Medical Equipment, Prosthetic, Orthotics and Supplies (DMEPOS)PayerPolicy · REGENCE-DME88 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Gene-Based Tests for Screening,Detection,and Management of Prostate or Bladder CancerPayerPolicy · REGENCE-GT17 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Gene Expression-Based Assays for Cancers of Unknown PrimaryPayerPolicy · REGENCE-GT15 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Gene Expression Profiling for MelanomaPayerPolicy · REGENCE-GT29 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Gender Affirming Interventions for Gender DysphoriaPayerPolicy · REGENCE-MED153 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Gastroesophageal Reflux SurgeryPayerPolicy · REGENCE-SUR186 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Gastric Electrical StimulationPayerPolicy · REGENCE-SUR111 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Galvanic StimulationPayerPolicy · REGENCE-DME83.01 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Functional Neuromuscular Electrical StimulationPayerPolicy · REGENCE-DME83.04 | Metadata changed |
|---|
| Aug 1, 2026 | Regence BCBS | Folate TestingPayerPolicy · REGENCE-LAB79 | Metadata changed |
|---|